Laboratory Tests

Comprehensive Clinical Hepatology

Volumn , Issue , 2006, Pages 73-81

  Imperial, Joanne C ^a   Keeffe, Emmet B ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882511763     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03675-7.50009-3     Document Type: Chapter

References (30)

1. Moseley FH Evaluation of abnormal liver function tests. Med Clin North Am 1996, 80:888.
2. Ahmed A, Keeffe EB Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia. Am J Gastroenterol 1998, 93:2598-2599.
3. Cohen JA, Kaplan MM The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Am J Dig Dis 1979, 24:835-838.
4. Daniel S, Ben-Menachem T, Vasudevan G, et al. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999, 94:3010-3014. Fatty liver is the most frequent cause of elevated aminotransferases in asymptomatic patients.
5. Flora KD, Keeffe EB Evaluation of mildly abnormal liver tests in asymptomatic patients. J Insur Med 1990, 22:264-267.
6. Flora KD, Keeffe EB Significance of mildly elevated liver tests on screening biochemistry profiles. J Insur Med 1990, 22:206-210.
7. Friedman LS, Dienstag JL, Watkins E, et al. Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med 1987, 107:137-144.
8. Hultcrantz R, Glaumann H, Lindberg G, et al. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986, 21:109-113.
9. Katkov WN, Friedman LS, Cody H, et al. Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus. Ann Intern Med 1991, 115:882-884.
10. Keeffe EB Diagnostic approach to mild elevation of liver enzyme levels. Gastrointest Dis Today 1994, 3:1-9.
11. Kundrotas LW, Clement DJ Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors. Dig Dis Sci 1994, 38:2145-2150.
12. Lindsay KL, Hoofnagle JH Serologic tests for viral hepatitis. Liver and biliary diseases 1996, 221-234. Williams & Wilkins, Baltimore. 2nd edn. N. Kaplowitz (Ed.).
13. Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of non-alcoholic fatty liver disease associated with normal ALT values. Hepatology 2003, 37:1286-1292. Points out that significant liver disease due to NAFLD may be present in the face of normal serum aminotransferases.
14. Neuschwander-Tetri BA, Caldwell SH Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 2003, 39:1201-1219.
15. Palmer M, Shaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990, 99:1408-1413.
16. Pratt DS, Kaplan MM Evaluation of abnormal liver-enzymes results in asymptomatic patients. N Engl J Med 2000, 342:1266-1271.
17. Rosen HR, Friedman LS, Martin P. Hepatitis C in renal dialysis and transplant patients. Viral Hepatitis Rev 1996, 2:97-110.
18. Williams ALB, Hoofnagle JH Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: relationship to cirrhosis. Gastroenterology 1988, 95:734-739. Documents that as liver disease due to viral hepatitis progresses to cirrhosis, AST becomes higher than ALT.
19. Yasuda K, Okuda K, Endo N, et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995, 109:1295-1300.
20. Keeffe EB, Sunderland MC, Gabourel JD Serum γ-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy. Dig Dis Sci 1986, 31:1056-1061.
21. Lieberman D, Phillips D. 'Isolated' elevation of alkaline phosphatase: significance in hospitalized patients. J Clin Gastroenterol 1990, 12:415-419.
22. Rubenstein LV, Ward NC, Greenfield S. In pursuit of the abnormal serum alkaline phosphatase: a clinical dilemma. J Gen Intern Med 1986, 1:38-43.
23. Wolf PL Clinical significance of an increased or decreased serum alkaline phosphatase level. Arch Pathol Lab Med 1978, 102:497-501.
24. Czaja AJ, Freese DK Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002, 36:479-497.
25. Dickson ER, Grambsch PM, Fleming TR, et al. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989, 10:1-7.
26. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33:464-470. Description of MELD score which is now widely used to allocate livers for transplantation.
27. Kim WR, Wiesner RH, Poterucha JJ, et al. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 2000, 6:489-494.
28. Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978, 75:193-199.
29. Marcellin P, Martinot-Peignoux M, Gabriel F, et al. Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction. J Hepatol 1993, 19:167-170.
30. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001, 7:567-580.